Home » AxioMed Gets $18 Million Second Round
AxioMed Gets $18 Million Second Round
Taking advantage of a spate of high-value acquisitions of spinal implant developers and recent U.S. government approval of the first artificial spinal disk, AxioMed Spine raised $18 million in a second round of venture capital led by Thomas, McNerney & Partners.
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct